Synergy Pharmaceuticals (SGYP) Slides on FDA Nod

Synergy Pharmaceuticals Inc's (NASDAQ: SGYP) shares faded 6.3% to $6.01, after the U.S. Food and Drug Administration approved the company’s plecanatide, brand. Share volume was 14.5 million, compared to an all-day average of 4.4 million